Skip to main content
PMC home page
Springer logoLink to Springer
. 2016 Sep 26;27(11):587–598. doi: 10.1007/s00335-016-9664-5

Viable EdnraY129F mice feature human mandibulofacial dysostosis with alopecia (MFDA) syndrome due to the homologue mutation

Sibylle Sabrautzki 1,2, Michael A Sandholzer 1,3, Bettina Lorenz-Depiereux 4, Robert Brommage 1, Gerhard Przemeck 1,5, Ingrid L Vargas Panesso 6,7, Alexandra Vernaleken 6,7, Lillian Garrett 8, Katharina Baron 9, Ali O Yildirim 3, Jan Rozman 1,5,10, Birgit Rathkolb 1,11, Christine Gau 1,5, Wolfgang Hans 1,5, Sabine M Hoelter 1,8, Susan Marschall 1, Claudia Stoeger 1, Lore Becker 1,5,6,7, Helmut Fuchs 1,5, Valerie Gailus-Durner 1,5, Martin Klingenspor 10, Thomas Klopstock 6,7,12, Christoph Lengger 1, Leuchtenberger Stefanie 1,5, Eckhard Wolf 11, Tim M Strom 4,15, Wolfgang Wurst 8,12,13,14, Martin Hrabě de Angelis 1,5,16,✉
PMCID: PMC5110705  PMID: 27671791

Abstract

Animal models resembling human mutations are valuable tools to research the features of complex human craniofacial syndromes. This is the first report on a viable dominant mouse model carrying a non-synonymous sequence variation within the endothelin receptor type A gene (Ednra c.386A>T, p.Tyr129Phe) derived by an ENU mutagenesis program. The identical amino acid substitution was reported recently as disease causing in three individuals with the mandibulofacial dysostosis with alopecia (MFDA, OMIM 616367) syndrome. We performed standardized phenotyping of wild-type, heterozygous, and homozygous Ednra Y129F mice within the German Mouse Clinic. Mutant mice mimic the craniofacial phenotypes of jaw dysplasia, micrognathia, dysplastic temporomandibular joints, auricular dysmorphism, and missing of the squamosal zygomatic process as described for MFDA-affected individuals. As observed in MFDA-affected individuals, mutant Ednra Y129F mice exhibit hearing impairment in line with strong abnormalities of the ossicles and further, reduction of some lung volumetric parameters. In general, heterozygous and homozygous mice demonstrated inter-individual diversity of expression of the craniofacial phenotypes as observed in MFDA patients but without showing any cleft palates, eyelid defects, or alopecia. Mutant Ednra Y129F mice represent a valuable viable model for complex human syndromes of the first and second pharyngeal arches and for further studies and analysis of impaired endothelin 1 (EDN1)–endothelin receptor type A (EDNRA) signaling. Above all, Ednra Y129F mice model the recently published human MFDA syndrome and may be helpful for further disease understanding and development of therapeutic interventions.

Electronic supplementary material

The online version of this article (doi:10.1007/s00335-016-9664-5) contains supplementary material, which is available to authorized users.

Introduction

Studies in humans and in animal models have indicated an essential role of the endothelin 1 (EDN1,2)–endothelin receptor type A (EDNRA) signaling in normal craniofacial development. Within the large family of syndromes of the first and second pharyngeal arches, craniofacial deformities in humans may occur as single characteristic without any further organ anomalies, e.g., observed in auriculocondylar syndrome (ACS, OMIM 602483, 614669, and 615706) due to disruption of the EDNRA signaling pathway (Clouthier et al. 2013; Gordon et al. 2013) or may occur with further organ anomalies, e.g., observed in oculo-auriculo-vertebral spectrum (OAVS, OMIM 164210). It was described for mouse embryos and zebrafish larvae that Edn1 is required for the formation of ventral arch cartilage and bones (dentary, hyoid, thyroid, and tympanic ring bone), while the formation of more proximal cartilage and bones such as maxilla, palatine, and pterygoid is inhibited (Clouthier et al. 2010). Thus, in ACS as a well-characterized rare craniofacial disorder affecting early neural crest cell (NCC) development within the first and second pharyngeal arches, clinical characteristics manifest usually within structures developed from differentiated NCCs like the bones of the upper and lower jaw, the ossicles, the outer ear, and the neck (Passos-Bueno et al. 2009; Ruest and Clouthier 2009). In addition to several other genes, mutations of EDN1 were reported to cause auriculocondylar syndrome 3 in patients (ARCND3, OMIM 615706) (Gordon et al. 2013). In mouse models, mutations of genes of the endothelin-1 pathway led to craniofacial symptomatology, as mice harboring a targeted mutation either in Edn1 (MGI:95283), Ednra (MGI:105923), or the endothelin-converting enzyme-1 gene (Ece1; MGI:1101357) coding for an enzyme responsible for the processing of inactive big-EDN1 to active EDN1 were born with craniofacial and cardiovascular malformations (Kurihara et al. 1994; Clouthier et al. 1998; Yanagisawa et al. 1998; Kitazawa et al. 2011). Examining abnormalities associated with disruptions in these mouse genes was limited so far as knockouts exhibited embryonic or neonatal lethality.

Recently, sequence analysis of one patient with severe craniofacial abnormalities, alopecia, ear malformations, and conductive hearing loss in line with developmental delay, originally described for Johnson–McMillin syndrome (Cushman et al. 2005), revealed that these abnormalities were due to a de novo missense mutation within the EDNRA gene as additionally isolated in two other patients. Thus, a new syndrome was suggested as mandibulofacial dysostosis with alopecia (MFDA, OMIM 616367) (Gordon et al. 2015).

Here, we describe a new viable Ednra Y129FMhda mouse model carrying the homologue point mutation of the three patients reported with MFDA (Gordon et al. 2015). The model was derived by the Munich N-ethyl-N-nitrosourea (ENU) mutagenesis project used for more than a decade as a forward genetic approach to generate mutant mouse models for inherited human diseases (Hrabě de Angelis et al. 2000; Sabrautzki et al. 2012). Using the standardized phenotyping platform of the German Mouse Clinic (GMC) (Gailus-Durner et al. 2009; Fuchs et al. 2012), we observed a diversity of dysmorphological, otolaryngeal, and lung phenotypes by comparison of adult heterozygous (Ednra Y129F/+) and homozygous (Ednra Y129F/Y129F) mice with their wild-type littermates (Ednra +/+). Our results may contribute to reveal single-gene contribution in MFDA and may be helpful to develop a treatment strategy for patients (Gordon et al. 2015).

Materials and methods

ENU mutagenesis and mice

ENU mutagenesis was performed on the pure inbred C3HeB/FeJ (C3H) mouse strain purchased originally from the Jackson Laboratory (Bar Harbour, Maine) as previously described (Aigner et al. 2011; Sabrautzki et al. 2012). The mice were housed and handled according to the federal animal welfare guidelines and the responsible authority of Upper Bavaria approved all animal studies (Reference Numbers 55.2-1-54-2532-78-06 and 55.2-1-54-2532-144-10). The mouse line was given the internal lab code AEA001 (abnormal ear #1) according to the big bat-like ears. Heterozygous intercrosses led to homozygous offspring in a Mendelian ratio that were smaller than heterozygous littermates and showed bigger ears. After the causative mutation was isolated, the mouse line was given the official name Ednra Y129FMhda.

Phenotyping in the GMC

Phenotyping was performed in the GMC according to the standardized IMPReSS protocols (www.mousephenotype.org). Depending on the individual screens, cohorts of 9–15 Ednra Y129F/+, Ednra Y129F/Y129F, and Ednra +/+ mice per gender were analyzed in the age of 9–16 weeks. Phenotyping was performed by a total of fourteen independent screens (Fuchs et al. 2011). A summary of all phenotyping protocols is provided in Table S1.

pQCT measurement

Femur midshafts and distal metaphyses of Ednra Y129F/+ mice were scanned by pQCT (Norland Stratec XCT, Stratec Medizintechnik GmbH, Pforzheim, Germany) at 3, 6, 9, and 12 months of age for the analyses of total bone area, bone mineral content (BMC), and bone mineral density (BMD) without distinguishing between cortical and trabecular bone. Two pQCT scan slices were obtained at each site, with voxel dimensions of 70 × 70 × 500 µm providing data for 1 mm of bone length.

Micro-CT analysis and cephalometric measurement

Adult skulls (26- to 30-week-old mice) were imaged using a SkyScan 1176 in vivo CT (Bruker micro-CT N.V., Kontich, Belgium) at 9 µm pixel resolution using 100 kV voltage, 100 mA current, and a 0.5 mm aluminum filter. The resulting slices were reconstructed with SkyScan’s NSRECON package using uniform attenuation coefficient data as previously described (Sabrautzki et al. 2013; Sandholzer et al. 2014). In total, eight datasets were evaluated by two experienced osteologists using the distance measurement tool of 3DSlicer 4.5 (available online: www.slicer.org). Cranial and mandibular reference points on the bone surface (Fig. 1) were selected based on previously described landmarks (De Carlos et al. 2011). Soft-tissue contrast enhancement was reached by staining with an Iodine–Potassium Iodine solution for 2 weeks, with the solution exchanged every 48 h.

Fig. 1.

Fig. 1

Open in a new tab

Landmarks of cephalometric/mandibular measurement

Whole mount analysis of middle and inner ears

Samples were fixed in paraformaldehyde, dehydrated in ethanol series, and made translucent using methyl-salicylate. Afterwards, the translucent inner ears were observed and photographed using top and bottom illumination under the microscope.

Lung analysis

For analysis of pulmonary function, five Ednra +/+, six Ednra Y129F/+, and six Ednra Y129F/Y129F female mice were used. The anesthetized mice were tracheotomized and ventilated during the experiment. Briefly, a FinePointe RC system (Buxco, Wilmington, USA) was used to measure dynamic lung compliance (Cdyn) and resistance. Afterwards, the mice were transferred to a Biosystem XA forced maneuvers system (Buxco, Wilmington, USA) to measure forced expiratory volume in 0.1 s (FEV0.1), forced vital capacity (FVC), functional residual capacity (FRC), total lung capacity (TLC), tidal volume (TV), inspiratory capacity (IC), expiratory reserve volume (ERV), vital capacity (VC), residual volume (RV), and static lung compliance (Cchord).

Statistical analyses

Statistical analyses were done using t test, Wilcoxon rank-sum test, linear models, or ANOVAs, depending on the assumed distribution of the parameter and the questions addressed to the data. A P value <0.05 has been used as the level of significance; a correction for multiple testing has not been performed.

Genetic mapping

For genetic mapping, phenotypically heterozygous mice were backcrossed with C57BL/6J (B6) mice, and DNA was extracted from tail tips from 44 mutant and 37 wild-type B6–C3H hybrid mice for linkage analysis as described previously (Aigner et al. 2011). Genotyping was performed by single-nucleotide polymorphism (SNP) analysis using MassExtend (MALDI-TOF MS genotyping system) (Sequenom, San Diego, CA, USA) as previously described (Sabrautzki et al. 2012).

Exome sequencing

DNA extraction from the spleens was performed using ProteinaseK, RNaseA, CellLysis Solution, Protein Precipitation Solution, and DNA Hydration Solution from Qiagen according to the manufacturer’s manual (Qiagen, Venlo,the Netherlands). In-solution targeted enrichment of exonic sequences from both the phenotypically mutant and the control wild-type littermate mouse using the SureSelectXT Mouse All Exon kit (Agilent, Santa Clara, CA, USA) was performed. Libraries were sequenced as 100 bp paired-end runs on a HiSeq 2000 system (Illumina, San Diego, CA, USA). Read alignment to mouse genome assembly mm9 was done with Burrows-Wheeler Aligner (BWA, version 0.5.9), and a total of 10 and 9.2 Gb of mapped sequence data corresponding to an average coverage of 120× (>95 % of the target being covered >20×) and 113× for the mutant and control, respectively, were yielded. Single-nucleotide variants (SNVs) and small insertions and deletions (indels) were detected with SAMtools (v. 0.1.7).

Results

Genotypic identification of a new ENU-derived mouse model

Using the sources of the large-scale genome-wide Munich ENU mutagenesis project (MEP), a mouse line with craniofacial and ear abnormalities was identified (AEA001, abnormal ear #1), thereby showing an autosomal dominant mode of inheritance. Linkage analysis gave a highest Chi square for a region on chromosome eight between the genomic markers rs13479782 and rs13479952 (NCBI137/mm9_chr8:60,521,202-103,433,460, ~43 Mb, UCSC). Due to the high number of candidate genes within this large region, we performed whole exome sequencing for mutation detection. By comparing and filtering the sequencing data as described previously (Sabrautzki et al. 2013; Diener et al. 2016), we obtained 11 candidate SNVs. Three candidate SNVs were located within the candidate linkage interval on mouse chromosome 8. Although linkage data were available, we decided to analyze all 11 variants of interest within a cohort of 10 wild-type and 16 mutant mice by capillary sequencing. Only one SNV on mouse chromosome 8, genomic position NCBI137/mm9_chr8:80,243,961, segregated in all mutant mice analyzed with the phenotype. This private SNV was a heterozygous non-synonymous sequence variation within the Ednra gene (NM_010332.2:c.386A>T, NP_034462.1:p.Tyr129Phe). Thus, the AEA001 mouse line was renamed as Ednra Y129FMhda. Recently, in humans the non-synonymous sequence variation within the EDNRA gene at the corresponding position (NM_001957.3:c.386A>T, NP_001948.1:p.Tyr129Phe) was published as disease causing in three unrelated individuals with MFDA (OMIM 616367) (Gordon et al. 2015).

Morphological changes in EdnraY129F mice

Mutant Ednra Y129F mice showed craniofacial abnormalities as short snout, round facial, and shortened head appearance, further prominent cheeks, micrognathia, and significantly malformed big bat-like ears (Fig. 2a, b, c). The low-settled ears had a tapered helix, and the eyes of some mice seemed to be enlarged. Ednra Y129F/Y129F mice were viable and fertile but displayed a visibly decreased body size compared to Ednra +/+ and Ednra Y129F/+ mice with shortening and flattening of the skull in some but not all Ednra Y129F/Y129F mice. We observed a general inter-individual variance in the severity of phenotype expression among the mutant genotypes.

Fig. 2.

Fig. 2

Open in a new tab

Visible ear and eye abnormalities of Ednra Y129F/+ and Ednra Y129F/Y129F mice

Micro-CT imaging of craniofacial phenotypes

Three-dimensional micro-CT analysis and measurements revealed bones of the skull misshaped or underdeveloped in Ednra Y129F/+ and Ednra Y129F/Y129F mice (Fig. 3, Movies M1–M3). The dorsal view depicted broadening of the sagittal, coronal, and anterior lambdoid sutures of an Ednra Y129F/Y129F mouse (Fig. 3d) and broadened zygomatic bones without any sutures in both Ednra Y129F/Y129F mice (Fig. 3d, e). In the lateral view, the absence of the zygomatic process of the squamosal bone was obvious in both Ednra Y129F/Y129F mice (Fig. 3i, j), as also seen in Ednra Y129F/+ mouse #1 (Fig. 3g). In these three mice (Fig. 3g, i, j), the zygomatic bone, connecting the malar and squamosal zygomatic processes, appeared fused without any suture (Movie M1). In addition, the shape of the zygomatic bone was abnormal in these mice when compared to the Ednra +/+ mouse (Fig. 3f). In Ednra Y129F/+ mouse #2 (Fig. 3h), the squamosal part of the zygomatic process appeared to be present, as indicated by the existence of a suture but with a gap to the zygomatic bone. Similar to the findings in MFDA patients, we observed morphological changes of the orbit in mutant Ednra Y129F mice. The orbit appeared round and with thickened malar zygomatic bone in Ednra Y129F/Y129F mice, while in the Ednra +/+ mouse the orbit had an oval appearance. No dental abnormalities or cleft palates were found in mutant Ednra Y129F mice. A malocclusion of molar teeth was observed in Ednra Y129F/Y129F mouse #2 (Fig. 3j) and a minor malocclusion in Ednra Y129F/+ mouse #2 (Fig. 3h). Altogether, the bone abnormalities of the skull in mutant mice were highly similar to the changes found in clinical CT scans of MFDA patients (Gordon et al. 2015).

Fig. 3.

Fig. 3

Open in a new tab

Micro-CT analysis of the dorsal (a–e), left lateral view (f–j) of the skull and lateral view of the mandible (k–o)

Jaw dysplasia of the mandibular condyloid process was visible in all mutant mice investigated (Fig. 3l, m, n, o; Movie M2). In accordance with observations in MFDA patients, Ednra Y129F/+ and Ednra Y129F/Y129F mice showed micrognathia by mandibular shortening of the diastema (8.1 % in three Ednra Y129F/+ and 14.6 % in two Ednra Y129F/Y129F mice; Table 1). Furthermore, an abnormality of the temporomandibular joint in mutant mice was evident (Movie M3).

Table 1.

Craniometric and mandibular measurements of eight Ednra mice (Ednra +/+ n = 3, Ednra Y129/+ n = 3, Ednra Y129F/Y129F n = 2)

ID Genotype A [1–2] B [3–4] C [3–5] D [4–5] E [6–7] Ratio C/A
1 Ednra +/+ 6.19 11.8 11.8 3.6 23.9 1.91
2 Ednra +/+ 6.11 11.5 11.4 3.5 23.1 1.87
3 Ednra +/+ 6.23 10.9 11.1 3.4 23.9 1.78
4 Ednra Y129F/Y129F 6.61 11.3 11.1 3.2 22.1 1.68
5 Ednra Y129F/+ 6.25 11 10.7 3.1 22 1.71
6 Ednra Y129F/+ 6.35 11.1 10.9 3 22.4 1.72
7 Ednra Y129F/Y129F 6.96 10.9 11.2 2.6 23.3 1.61
8 Ednra Y129F/Y129F 6.82 10.3 10.6 2.5 22.6 1.55
Mean C/A ratio Ednra +/+ 1.85 Ednra Y129F/+ 1.70 Ednra Y129F/Y129F1.58
Open in a new tab

Measurement points: (1) palatinal intra-incisor-alveolar point, (2) palatinal-molar-alveolar point, (3) buccal incisor-alveolar point, (4) most inferior point of the Processus condylaris, (5) most superior posterior point of the Processus angularis, (6) most dorsal point of the Foramen magnum at the Os occipitale, and (7) most caudal point of the Os nasale. Mean distance in mm

Hearing impairment

In line with the conductive hearing loss of all MFDA patients (Gordon et al. 2015), mild hearing impairment was observed in Ednra Y129F/+ mice. An even stronger hearing loss in Ednra Y129F/Y129F mice was demonstrated by auditory brainstem response ABR analysis with thresholds increased by 25 and 50 dB, respectively, compared to the thresholds obtained for Ednra +/+ mice for both click (Fig. 4a) and pure tone stimuli (Fig. 4b). Conductive hearing impairment for mutant mice was further affirmed by behavioral tests. Acoustic startle reactivity was significantly decreased (P < 0.001) in Ednra Y129F/Y129F mice compared to Ednra +/+ and Ednra Y129F/+ mice (Fig. S1). Moreover, there was decreased prepulse inhibition (PPI) in mutant mice, with a significant reduction in Ednra Y129F/Y129F mice at all prepulse intensities (Fig. S2).

Fig. 4.

Fig. 4

Open in a new tab

ABR thresholds for click and tone-evoked potentials in Ednra +/+, Ednra Y129F/+, and Ednra Y129F/Y129F mice

Malformations of the malleus and incus were found by micro-dissections of the ossicles in adult mice. The malleal bodies appeared slimmer with planar-shaped facets in mutant mice, and stronger changes were seen in Ednra Y129F/Y129F mice. The short process of the incus was missing in both mutant mice. Dissection of the petrosal bone revealed abnormal closure of the ringbone and confirmed abnormally shaped incudo-malleal joints in the mutant mice (Fig. 5).

Fig. 5.

Fig. 5

Open in a new tab

Middle and inner ears of Ednra +/+ (left), Ednra Y129F/+ (middle), and Ednra Y129F/Y129F (right) mice

Decreased lung volumetric parameters

Two of the MFDA patients showed upper airway obstruction necessitating tracheostomy (Gordon et al. 2015). In the micro-CT datasets of contrast-enhanced soft tissue of the upper airways, no clearly visible morphological changes were observed (data not shown). The lung function analysis showed that Ednra Y129F/+ and Ednra Y129F/Y129F mice concomitantly exhibited decreased volumetric parameters in lung function analysis for IC, VC, ERV, and TLC with genotype-related severity for some parameters. In Ednra Y129F/Y129F mice, further to volumetric parameters FVC and forced expiratory volume (FEV 100) as flow parameters were significantly decreased. Additionally, one mechanical parameter, the Cchord, was decreased in Ednra Y129F/Y129F mice (Table 2).

Table 2.

Significant volumetric parameter alterations following lung function analysis of female Ednra Y129F/+ , Ednra Y129F/Y129F, and Ednra +/+ mice (mean ml ± SD)

Ednra Y129F/+ Ednra Y129F/Y129F Ednra +/+
Volumetric parameters
 IC 0.967 ± 0.12 (P < 0.05) 0.775 ± 0.097 (P < 0.01) 1.138 ± 0.127
 VC 1.32 ± 0.17 (P < 0.05) 1.08 ± 0.12 (P < 0.01) 1.56 ± 0.17
 ERV 0.36 ± 0.06 (ns) 0.31 ± 0.04 (P < 0.01) 0.42 ± 0.05
 TLC 1.295 ± 0.161 (ns) 1.112 ± 0.07 (P < 0.01) 1.496 ± 0.156
Flow parameters
 FVC 1.082 ± 0.141 (P < 0.05) 0.915 ± 0.109 (P < 0.01) 1.348 ± 0.149
 FEV100 0.923 ± 0.122 (ns) 0.835 ± 0.086 (P < 0.01) 1.07 ± 0.097
Mechanical parameters
 Cchorda 0.085 ± 0.0105 (ns) 0.0683 ± 0.01 (P < 0.0098) 0.096 ± 0.012
Open in a new tab

Cchord static lung compliance, ERV expiratory reserve volume, FEV100 forced expiratory volume, FVC forced vital capacity, IC inspiratory capacity, TLC total lung capacity, VC vital capacity, ns not significant

a (ml/cm H2O)

Additional minor findings

Besides the observed major craniofacial abnormalities, we also found mild morphologic postcranial bone changes. Femoral metaphyseal and diaphyseal bone area in mice, BMC, and BMD measured at 3, 6, 9, and 12 months of age were slightly reduced in Ednra Y129F/+ male and female mice but these reductions did not consistently reach statistical significance. Averaging values for males and females over all ages gave reductions of 6, 5, and 0 % for diaphyseal area, BMC, and BMD, respectively (Fig. S3). Similarly, metaphyseal area, BMC, and BMD were reduced 3, 5, and 1 %, respectively.

Ednra Y129F/Y129F mice appeared with a visible reduced body size, as observed in Endra −/− P0 mice (Clouthier et al. 1998), and also significantly reduced body weight (P < 0.001). Mean body weight was 23.58 ± 2.35 g in female and 28.31 ± 3.57 g in male Ednra Y129F/Y129F mice (female Ednra +/+: 28.65 ± 3.21 g; male Ednra +/+: 33.33 ± 3.41 g) in twelve-week-old mice. At the same age, in Ednra Y129F/Y129F but not in Ednra Y129F/+ mice (n = 15 for all groups), body mass was significantly reduced in NMR measurement (P < 0.001).

We did not observe alterations in analyses of the allergy, eye, clinical–chemical, cardiovascular, immunology, neurology, nociception, pathology, and steroid metabolism screen. Parameters showing only mild tendencies to alterations were not considered. All phenotypic data are shown on the GMC webpage (www.mouseclinic.de) under the line code AEA001.

Discussion

EDNRA has been shown to play a key role in craniofacial development (Clouthier et al. 2010; Twigg and Wilkie 2015). Detailed studies on the molecular regulation of craniofacial patterning were already performed using zebrafish, chick, and mouse embryos as targeted gene models (Miller et al. 2000; Ruest and Clouthier 2009; Zuniga et al. 2010). Here, we describe a new ENU mutagenesis-derived mouse model carrying a non-synonymous sequence variation within the Ednra gene leading to a replacement of the functionally important Tyr-129 residue within the transmembrane domain 2 of the receptor. In humans, the identical substitution is associated with the clinical spectrum of MFDA (Gordon et al. 2015), whereby alopecia is distinguishing this syndrome from other mandibulofacial dysostoses (MFD) (Wieczorek 2013). In Ednra Y129F mutant mice, numerous corresponding craniofacial characteristics such as dysplastic zygomatic arch with missing of the zygomatic process, micrognathia, dysplastic temporomandibular joints, typical changes of the orbital morphology, auricular dysmorphism, and conductive hearing loss were observed.

In addition to the abnormalities observed in patients with MFDA, we found volumetric airflow impairment in our mouse model. Breathing impairment in patients with MFDA was described due to upper airway obstruction without any closer specification (Gordon et al. 2015). We could not clearly detect any morphologic upper airway obstructions in our mouse model by soft-tissue contrast-enhanced micro-CT analysis so far. Nonetheless, female Ednra Y129F/+ and Ednra Y129F/Y129F mice showed decreased volumetric parameters in lung function analysis. EDNRA caused human cellular airway smooth muscle proliferation when ligated to endothelin (Panettieri et al. 1996, 2008). In tracheostomized E18.5 Ednra-null pups, no changes of respiratory minute volume were observed but decreased ventilatory responses following breathing of hypoxic gas, suggesting that this observation was due to impaired early central respiratory control (Clouthier et al. 1998). Whether breathing impairment observed in MFDA-affected patients and in our mouse model may derive from upper or lower airway defects or both or are due to central defects is still unclear.

MFDA-affected individuals presented severe outer craniofacial malformations such as dysplastic zygomatic arch and mandible and jaw deformity confirmed by clinical CT scans of the skull. Broadening of the zygomatic bone together with missing of the squamosal zygomatic process was visible in some of the Ednra Y129F/+ and Ednra Y129F/Y129F mice, in line with deformities of the temporomandibular joint. Three of the reported MFDA patients with heterozygous de novo mutations within the EDNRA gene were reported for conductive, but not specified, hearing loss (Gordon et al. 2015). For hearing impairment and cephalometric measurements in our mouse line, we found significant differences between Ednra +/+, Ednra Y129F/+, and Ednra Y129F/Y129F mice with a gene-dosage effect in mutant mice. More strikingly and in contrast to E18.5 Ednra-null embryos or newborn Ece-1 −/− mice, in which the malleus and incus as well as the tympanic ring were completely missing (Clouthier et al. 1998; Yanagisawa et al. 1998), we found malleus and incus malformed, but almost normal stapes in Ednra Y129F/+ and Ednra Y129F/Y129F mice. The endothelin signaling plays an important role in the development of skeletal elements that form the middle ear, involving the tympanic ring and the auditory ossicles (Ruest and Clouthier 2009). Malleus, incus, and tympanic ring are endochondral bones that derive from the first pharyngeal arch, while the stapes derive from the second pharyngeal arch (Mallo and Gridley 1996). Changes in the morphology and organization of the ossicles may impair the transmission of sound from the tympanic membrane to the cochlear oval window. We propose that the abnormal development of the tympanic ring affected the normal development of the middle ear cavity and tympanic membrane, thus causing aberrant three-dimensional positioning of the ossicles in the auditory bulla of our mice. We also hypothesize that the decreased acoustic startle reaction and PPI inhibition were secondary effects due to the hearing disability.

Ednra expression was shown for the first time in hair and vibrissal follicles of E15.5 Ednra lacz/+ mouse embryos (Gordon et al. 2015). So far, no viable mouse model was available to study the impact of systemic impaired Ednra function on hair development in adult mice. Yet, we did not observe any alopecia in Ednra Y129F/+ or Ednra Y129F/Y129F mice as reported for MFDA-affected patients. Inherited alopecia is correlated with a number of abnormalities including hormonal factors, alterations of gene transcription factors, impaired morphogenesis of hair follicles, and other cell signaling pathways (Tomann et al. 2016). However, how these and other underlying factors are exactly linked to healthy or aberrant morphology, hair follicle cycling, and subsequently hair loss is still unclear.

We further did not find any cleft palates in the analyzed mice of our cohort so far, as we could not observe any cleft palates in any of all our ENU mutagenesis-derived mouse models (930 mouse lines, unpublished data). Although cleft palates could be induced by triamcinolone in murine C3H strains when administered at E11.5 (Andrew et al. 1973), the C3H background probably is not sufficiently modeling human cleft palates (Juriloff and Harris 2008).

Edn-1 as a ligand of Ednra seems to be a key player for osteoblast differentiation by activating osteoblast signaling pathways, e.g., by activating Wnt signaling in bone (Clines et al. 2007), which additionally was shown by deletion of the Edn-1 receptor (Ednra) in osteoblasts leading to reduced bone mass (Clines et al. 2011). We observed only minor reductions in bone mass in male and female Ednra Y129F/+ mice examined between 3 and 12 months of age. However, reductions in bone area and BMC were consistent with reduced body size and normal BMD indicating appropriately bone mass for slightly smaller bones, thus suggesting that the postcranial skeleton was not affected by the mutation.

However, we did not find any cleft palates, hypoplastic eyelids, alopecia, or dental abnormalities. As observed in MFDA-affected individuals, phenotypic outcome in our mouse model resulted in high individual variability of the phenotype. For some observations, a gene-dosage effect could be demonstrated by comparing Ednra Y129F/+ with Ednra Y129F/Y129F mice.

So far, all available mouse models with a disruption of the Ednra gene were embryonically or perinatally lethal (Kurihara et al. 1994). In addition, no loss-of-function (LoF) mutation within the EDNRA gene was observed within the dataset of the human Exome Aggregation Consortium (ExAC Browser, www.exac.broadinstitut.org) providing exome sequencing data of 60,706 unrelated individuals of various disease-specific and population genetic studies. Instead of a complete loss of EDNRA such as in Ednra-null mice, an impaired Ednra function due to a change in ligand binding affinity caused by the Tyr-129 substitution (Krystek et al. 1994; Lee et al. 1994) leads to the phenotype in Ednra Y129F/+ and Ednra Y129F/Y129F mice and patients with MFDA. Under physiological conditions, the two different ligands Edn1 and Edn2 bind to the G-protein-coupled Ednra, while all three ligands (Edn1–3) are binding to the endothelin B receptor (Ednrb) with specific affinities (Yanagisawa et al. 1998; Clouthier et al. 2010). We speculate that the substitution of Tyr-129 to Phe within the binding side of the ligand in EDNRA could have more than one effect, due to a reduction of Edn1/Edn2 receptor activation on one side and due to the gain of a physiological unknown activation of the receptor by Edn3 on the other side. The question of whether the Tyr129Phe exchange leads to a gain- or LoF mutation could not entirely be answered by the phenotypes observed in human patients and by zebrafish experiments (Gordon et al. 2015). Targeted inactivation of Edn1, Ednra, or Ece1 in mouse embryos caused the transformation of lower jaw structures into maxillary derivatives (Abe et al. 2007), and vice versa, mice ectopically overexpressing Edn1 showed an inverse transformation of the upper jaw into a mandible-like structure (Sato et al. 2008). Since the mutant EDNRA could rescue the phenotype in zebrafish lacking the endogenous Ednra genes, and further due to the malar abnormalities, possibly appearing as mandible-like structures, the non-synonymous sequence variation was suggested to be a gain-of-function mutation. Interestingly, in one of the Ednra Y129F/+ mice analyzed in detail the structures of the zygomatic arch obviously still did exist. Thus, we suggest that the findings of micrognathia, morphologic changes of the ossicles, and gene-dosage-dependant hearing loss contribute more likely to a LoF mutation hypothesis. Nevertheless, the murine phenotype is, like the human and zebrafish phenotype, dependent on the complex context-dependent regulation of the EDNRA signaling via its physiological ligand during early craniofacial development. Inter-individual penetrance of the phenotype was observed in MFDA-affected individuals like in Ednra Y129F/+ and Ednra Y129F/Y129F mice. Incomplete penetrance of the phenotype in autosomal dominant diseases may depend on genetic and environmental factors such as modifier genes, DNA sequence polymorphisms in regulatory elements, and random monoallelic expression of autosomal genes, where genes can be stably expressed, from either of the parental alleles (Cooper et al. 2013; Gendrel et al. 2016).

In conclusion, Ednra Y129F mice may serve as a valuable model to analyze endothelin signaling in syndromes resembling abnormalities of tissues derived from the first and second pharyngeal arches. We isolated the first viable mouse model for a systemic Ednra mutation and showed several bone abnormalities as observed in MFDA-affected individuals, but in more detail. Moreover, our mouse model could contribute to solve the so far open question on the functional nature of the mutation. Above all, our mouse model might be valuable for further analysis of symptoms observed in MFDA-affected individuals and for respective therapeutic interventions.

Summary statement

ENU mutagenesis-derived Ednra Y129F mice mimic craniofacial phenotypes of jaw dysplasia, micrognathia, dysplastic temporomandibular joints, auricular dysmorphism, and missing of the squamosal zygomatic process as described for MFDA-affected individuals.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 198 kb) (198.9KB, pdf)
Supplementary material 2 (PDF 197 kb) (197.6KB, pdf)
Supplementary material 3 (PDF 370 kb) (370.6KB, pdf)
Supplementary material 4 (DOCX 24 kb) (23.6KB, docx)
Supplementary material 5 (MP4 2419 kb) (2.4MB, mp4)
Supplementary material 6 (MP4 909 kb) (909.8KB, mp4)
Supplementary material 7 (MP4 762 kb) (762.9KB, mp4)

Acknowledgments

We thank Anja Wohlbier, Sören Kundt, Lisa Fees, and the team of technical assistants of the GMC for excellent technical assistance. We thank Sandy Lösecke and Susanne Diener for contributing to genetic analysis of the mouse model. We especially thank Sandra Hoffmann and Andreas Mayer for breeding performance of the mouse model, tissue sampling, and genotyping.

Finding

This work was supported by the Bundesministerium für Bildung und Forschung OSTEOPATH [Grant Number 01EC1006B], Nationales Genomforschungsnetz [Grant Number NGFN 01GR0430], Bundesministerium für Bildung und Forschung NGFNplus grants [Grant Numbers 01GS0850, 01GS0851], Bundesministerium für Bildung und Forschung grant to the German Center for Vertigo and Balance Disorders [grant number 01EO0901], EU ANABONOS [Grant Number LSH-2002-2.1.4-3], and Bundesministerium für Bildung und Forschung TAL-Cut-Technology grant [Grant Number 03V0261]. This work was also supported by the Helmholtz Portfolio Theme “Metabolic Dysfunction and Common Disease.”

Authors’ contribution

Performance of the study and participation in its design and coordination: SS, MAS, BLD, and MHdA. Drafting of the manuscript: SS, MAS, and BLD. Project leader of the Munich ENU mutagenesis project, generation of the AEA001 mouse line, coordination of breeding and sample distribution of the obtained ENU mouse lines, and phenotyping of blood samples: SS. Micro-CT settings, measurements, data analysis, and preparation of images, figures, and movies: MAS. Sample preparation including exome capture for exome sequencing, PCR, capillary sequencing, and RT-PCR validation: BLD. Analysis of pQCT data: RB. Skeletal preparations: GP. Ossicle dissection and preparation: ILVP. ABR analysis: AV. Auditory brain stem and PPI analysis in the GMC: LG. Analysis of skeletal landmarks of the skull: KB. Lung volumetric measurements in the GMC: AOY. Coordination of body composition analysis in the GMC: JR. Coordination of clinical chemistry analysis in the GMC: BR. Statistical analysis in the GMC: CG. Coordination of dysmorphological phenotyping in the GMC: HF and WH. Coordination of behavioral analysis in the GMC: SMH. Coordination of in vitro fertilization, embryo transfer, and sperm freezing for rederivations of the mouse line: SM. Coordination of mouse cohort breeding in the GMC: CS. Coordinator of the neurology screen in the GMC: LB. Scientific and Technical Head GMC: HF. Scientific Administrative Head GMC: VGD. Head of the neurology screen in the GMC: TK. Coordinator of data administration: CL. Manuscript coordinator in the GMC: LS. Head of the behavior screen in the GMC: WW. Participation in the conception of the mouse exome sequence and bioinformatics analysis, and the statistical evaluation: TMS. Heads and responsible coordinators of the ENU mutagenesis project: EW and MHdA. Director of the GMC: MHdA. All the authors read and approved the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Footnotes

The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint first authors.

Contributor Information

Sibylle Sabrautzki, Email: sabrautzki@helmholtz-muenchen.de.

Michael A. Sandholzer, Email: michael.sandholzer@helmholtz-muenchen.de

Bettina Lorenz-Depiereux, Email: lorenz-depiereux@helmholtz-muenchen.de.

Robert Brommage, Email: robert.brommage@helmholtz-muenchen.de.

Gerhard Przemeck, Email: przemeck@helmholtz-muenchen.de.

Ingrid L. Vargas Panesso, lunililita@googlemail.com

Alexandra Vernaleken, Email: alexandra@vernaleken.de.

Lillian Garrett, Email: Lillian.garrett@helmholtz-muenchen.de.

Katharina Baron, Email: katharina.baron@cfi.lbg.ac.at.

Ali O. Yildirim, Email: oender.yildirim@helmholtz-muenchen.de

Jan Rozman, Email: jan.rozman@helmholtz-muenchen.de.

Birgit Rathkolb, Email: birgit.rathkolb@helmholtz-muenchen.de.

Christine Gau, Email: christinegau@gmx.de.

Wolfgang Hans, Email: hansdawo@yahoo.com.

Sabine M. Hoelter, Email: hoelter@helmholtz-muenchen.de

Susan Marschall, Email: s.marschall@helmholtz-muenchen.de.

Claudia Stoeger, Email: claudia.stoeger@helmholtz-muenchen.de.

Lore Becker, Email: lore.becker@helmholtz-muenchen.de.

Helmut Fuchs, Email: hfuchs@helmholtz-muenchen.de.

Valerie Gailus-Durner, Email: gailus@helmholtz-muenchen.de.

Martin Klingenspor, Email: mk@tum.de.

Thomas Klopstock, Email: thomas.klopstock@med.uni-muenchen.de.

Christoph Lengger, Email: lengger@helmholtz-muenchen.de.

Leuchtenberger Stefanie, Email: leuchtenberger@helmholtz-muenchen.de.

Eckhard Wolf, Email: ewolf@lmb.uni-muenchen.de.

Tim M. Strom, Email: strom@helmholtz-muenchen.de

Wolfgang Wurst, Email: wurst@helmholtz-muenchen.de.

Martin Hrabě de Angelis, Phone: +49 (0) 89-3187-3502, Email: hrabe@helmholtz-muenchen.de.

References

  1. Abe M, Ruest LB, Clouthier DE. Fate of cranial neural crest cells during craniofacial development in endothelin-A receptor defined mice. Int J Dev Biol. 2007;51:97–105. doi: 10.1387/ijdb.062237ma. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aigner B, Rathkolb B, Klempt M, Wagner S, Michel D, et al. Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in hematological parameters. Mamm Genome. 2011;22:495–505. doi: 10.1007/s00335-011-9328-4. [DOI] [PubMed] [Google Scholar]
  3. Andrew FD, Bowen D, Zimmermann EF. Glucocorticoid inhibition of RNA synthesis and the critical period for cleft palate induction in inbred mice. Teratology. 1973;7:167–175. doi: 10.1002/tera.1420070208. [DOI] [PubMed] [Google Scholar]
  4. Clines GA, Mohammad KS, Bao Y, Stephens O, Suva LJ, et al. Dickkopf homologue 1 mediates endothelin-1-stimulated new bone formation. Mol Endocrinol. 2007;21:486–498. doi: 10.1210/me.2006-0346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clines GA, Mohammad KS, Grunda JM, Niewolna Clines KL, Niewolna M, et al. Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor. J Bone Miner Res. 2011;26:2523–2536. doi: 10.1002/jbmr.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, et al. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development. 1998;125:813–824. doi: 10.1242/dev.125.5.813. [DOI] [PubMed] [Google Scholar]
  7. Clouthier DE, Garcia E, Schilling TF. Regulation of facial morphogenesis by endothelin signaling: insight from mice and fish. Am J Med Genet A. 2010;152A:2962–2973. doi: 10.1002/ajmg.a.33568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clouthier DE, Passos-Bueno MR, Tavares AL, Lyonnet S, Amiel J, et al. Understanding the basis of auriculocondylar syndrome: insight from human, mouse and zebrafish genetic studies. Am J Med Genet C. 2013;163C:306–317. doi: 10.1002/ajmg.c.31376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013;132:1077–1130. doi: 10.1007/s00439-013-1331-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cushman LJ, Torres-Martinez W, Weaver DD. Johnson-McMillin syndrome: report of a new case with novel features. Birth Defects Res A. 2005;73:638–641. doi: 10.1002/bdra.20178. [DOI] [PubMed] [Google Scholar]
  11. de Carlos F, Alvares-Suárez A, Costilla A, Noval I, Vega JA et al. (2011) 3D-µCT cephalometric measurements in mice. In: Saba L (ed) Computed tomography—special applications. Chapter 9. 10.5772/24234. Available from http://www.intechopen.com/books/computed-tomography-special-applications/3d-ct-cephalometric-measurements-in-mice
  12. Diener S, Bayer S, Sabrautzki S, Wieland T, Mentrup B, et al. Exome sequencing identifies a nonsense mutation in Fam46a associated with bone abnormalities in a new mouse model for skeletal dysplasia. Mamm Genome. 2016;27:111–121. doi: 10.1007/s00335-016-9619-x. [DOI] [PubMed] [Google Scholar]
  13. Fuchs H, Gailus-Durner V, Adler T, Aguilar-Pimentel JA, Becker L, et al. Mouse phenotyping. Methods. 2011;53:120–135. doi: 10.1016/j.ymeth.2010.08.006. [DOI] [PubMed] [Google Scholar]
  14. Fuchs H, Gailus-Durner V, Neschen S, Adler T, Caminha Afonso L, et al. Innovations in phenotyping of mouse models in the German Mouse Clinic. Mamm Genome. 2012;23:611–622. doi: 10.1007/s00335-012-9415-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gailus-Durner V, Fuchs H, Adler T, Aguilar-Pimentel JA, Becker L, et al. Systemic first-line phenotyping. Methods Mol Biol. 2009;530:463–509. doi: 10.1007/978-1-59745-471-1_25. [DOI] [PubMed] [Google Scholar]
  16. Gendrel AV, Marion-Poll L, Katoh K, Heard E. Random monoallelic expression of genes on autosomes: parallels with X-chromosome inactivation. Semin Cell Dev Biol. 2016;56:100–110. doi: 10.1016/j.semcdb.2016.04.007. [DOI] [PubMed] [Google Scholar]
  17. Gordon CT, Petit F, Kroisel PM, Jakobsen L, Zechi-Ceide RM, et al. Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears. Am J Hum Genet. 2013;93:1–8. doi: 10.1016/j.ajhg.2013.10.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gordon CT, Weaver KN, Zecchi-Ceide RM, Madsen EC, Tavares ALP, et al. Mutations in the endothelin receptor type A cause mandibulofacial dysostosis with alopecia. Am J Hum Genet. 2015;96:519–531. doi: 10.1016/j.ajhg.2015.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hrabě de Angelis M, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet. 2000;25:444–447. doi: 10.1038/78146. [DOI] [PubMed] [Google Scholar]
  20. Juriloff DM, Harris MJ. Mouse genetic models of cleft lip with or without cleft palate. Birth Defects Res A. 2008;82:63–77. doi: 10.1002/bdra.20430. [DOI] [PubMed] [Google Scholar]
  21. Kitazawa T, Sato T, Nishiyama K, Asai R, Arima Y, et al. Identification and developmental analysis of endothelin receptor type-A expression cells in the mouse kidney. Gene Expr Patterns. 2011;11:371–377. doi: 10.1016/j.gep.2011.04.001. [DOI] [PubMed] [Google Scholar]
  22. Krystek SR, Jr, Patel PS, Rose PM, Fisher SM, Kienzle BK. Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. J Biol Chem. 1994;269:12383–12386. [PubMed] [Google Scholar]
  23. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 1994;368:703–710. doi: 10.1038/368703a0. [DOI] [PubMed] [Google Scholar]
  24. Lee JA, Elliott JD, Sutiphong JA, Friesen WJ, Ohlstein EH, et al. Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor. Proc Natl Acad Sci USA. 1994;91:7164–7168. doi: 10.1073/pnas.91.15.7164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mallo M, Gridley T. Development of the mammalian ear: coordinate regulation of formation of the tympanic ring and the external acoustic meatus. Development. 1996;122:173–179. doi: 10.1242/dev.122.1.173. [DOI] [PubMed] [Google Scholar]
  26. Miller CT, Schilling TF, Lee KH, Parker J, Kimmel CB. Sucker encodes a zebrafish endothelin-1 required for ventral pharyngeal arch development. Development. 2000;127:3815–3828. doi: 10.1242/dev.127.17.3815. [DOI] [PubMed] [Google Scholar]
  27. Panettieri RA, Jr, Goldie RG, Rigby PJ, Eszterhas AJ, Hay DW. Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon. Br J Pharmacol. 1996;118:191–197. doi: 10.1111/j.1476-5381.1996.tb15385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Panettieri RA, Jr, Kotlikoff MI, Gerthoffer WT, Hershenson MB, et al. Airway smooth muscle in bronchial tone, inflammation, and remodeling: basic knowledge to clinical relevance. Am J Respir Crit Care Med. 2008;177:248–252. doi: 10.1164/rccm.200708-1217PP. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Passos-Bueno MR, Ornelas CC, Fanganiello RD. Syndromes of the first and second pharyngeal arches: a review. Am J Med Genet A. 2009;159A:1853–1859. doi: 10.1002/ajmg.a.32950. [DOI] [PubMed] [Google Scholar]
  30. Ruest LB, Clouthier DE. Elucidating timing and function of endothelin-A receptor signaling during craniofacial development using neural crest cell-specific gene deletion and receptor antagonism. Dev Biol. 2009;328:94–108. doi: 10.1016/j.ydbio.2009.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sabrautzki S, Rubio-Aliaga I, Hans W, Fuchs H, Rathkolb B, et al. New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis. Mamm Genome. 2012;23:416–430. doi: 10.1007/s00335-012-9397-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sabrautzki S, Janas E, Lorenz-Depiereux B, Calzada-Wack J, Aguilar-Pimentel JA, et al. An ENU mutagenesis-derived mouse model with a dominant Jak1 mutation resembling phenotypes of systemic autoimmune disease. Am J Pathol. 2013;183:352–368. doi: 10.1016/j.ajpath.2013.04.027. [DOI] [PubMed] [Google Scholar]
  33. Sandholzer MA, Baron K, Heimel P, Metscher BD. Volume analysis of heat-induced cracks in human molars: a preliminary study. J Forensic Dent Sci. 2014;6:139–144. doi: 10.4103/0975-1475.132545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sato T, Kawamura Y, Asai R, Amano T, Uchijima Y, et al. Recombinase-mediated cassette exchange reveals the selective use of Gq/G11-dependent and -independent endothelin1/endothelin type A receptor signaling in pharyngeal arch development. Development. 2008;135:755–765. doi: 10.1242/dev.012708. [DOI] [PubMed] [Google Scholar]
  35. Tomann P, Paus R, Miller SE, Scheidereit C, Schmidt-Ullrich R. LHX2 is a direct NF-κB target gene that promotes primary hair follicle placode down-growth. Development. 2016;143:1512–1522. doi: 10.1242/dev.130898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Twigg SRF and Wilkie AOM New insights into craniofacial malformations. Hum Mol Genet. 2015;24:R50–R59. doi: 10.1093/hmg/ddv228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wieczorek D. Human facial dysostoses. Clin Genet. 2013;83:499–510. doi: 10.1111/cge.12123. [DOI] [PubMed] [Google Scholar]
  38. Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, et al. Dual genetic pathways of endothelin mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development. 1998;125:825–836. doi: 10.1242/dev.125.5.825. [DOI] [PubMed] [Google Scholar]
  39. Zuniga E, Stellabotte F, Crump JG. Jagged-Notch signaling ensures dorsal skeletal identity in the vertebrate face. Development. 2010;137:1843–1852. doi: 10.1242/dev.049056. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material 1 (PDF 198 kb) (198.9KB, pdf)
Supplementary material 2 (PDF 197 kb) (197.6KB, pdf)
Supplementary material 3 (PDF 370 kb) (370.6KB, pdf)
Supplementary material 4 (DOCX 24 kb) (23.6KB, docx)
Supplementary material 5 (MP4 2419 kb) (2.4MB, mp4)
Supplementary material 6 (MP4 909 kb) (909.8KB, mp4)
Supplementary material 7 (MP4 762 kb) (762.9KB, mp4)

Articles from Mammalian Genome are provided here courtesy of Springer

RESOURCES